This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes

The University of Oxford and Novo Nordisk has announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and the University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on the premises of the University of Oxford.

For the full story on University of Oxford website